Acipimox is a niacin derivative used as a hypolipidemic agent.Target Acipimox is a niacin derivative used as a hypolipidemic agent. It is used in low doses and may have less marked adverse effects although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid.

For R&D use onlynot for drug household or other uses.

Acipimox (trade name Olbetam in Europe) is a niacin derivative used as a lipid-lowering agent. It reduces triglyceride levels and increases HDL cholesterol. It may have less marked adverse effects than niacin although it is unclear whether the recommended dose is as effective as standard doses of niacin.